217 related articles for article (PubMed ID: 24843144)
1. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.
Fouts AE; Comps-Agrar L; Stengel KF; Ellerman D; Schoeffler AJ; Warming S; Eaton DL; Feierbach B
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8209-14. PubMed ID: 24843144
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
3. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.
Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N
J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252
[TBL] [Abstract][Full Text] [Related]
4. Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes.
Loughney JW; Rustandi RR; Wang D; Troutman MC; Dick LW; Li G; Liu Z; Li F; Freed DC; Price CE; Hoang VM; Culp TD; DePhillips PA; Fu TM; Ha S
J Biol Chem; 2015 Jun; 290(26):15985-95. PubMed ID: 25947373
[TBL] [Abstract][Full Text] [Related]
5. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
[TBL] [Abstract][Full Text] [Related]
6. Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies.
Ai Y; Wu C; Zhang M; Jaijyan DK; Liu T; Zan L; Li N; Yu W; Wang Y; Yuan X; Li C; Zheng W; Zhu H; Liao HX
Microbiol Spectr; 2022 Dec; 10(6):e0139322. PubMed ID: 36342276
[TBL] [Abstract][Full Text] [Related]
7. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.
Freed DC; Tang Q; Tang A; Li F; He X; Huang Z; Meng W; Xia L; Finnefrock AC; Durr E; Espeseth AS; Casimiro DR; Zhang N; Shiver JW; Wang D; An Z; Fu TM
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4997-5005. PubMed ID: 24297878
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions.
Manley K; Anderson J; Yang F; Szustakowski J; Oakeley EJ; Compton T; Feire AL
Cell Host Microbe; 2011 Sep; 10(3):197-209. PubMed ID: 21925108
[TBL] [Abstract][Full Text] [Related]
9. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity.
Cui X; Cao Z; Wang S; Flora M; Adler SP; McVoy MA; Snapper CM
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261659
[TBL] [Abstract][Full Text] [Related]
10. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.
Macagno A; Bernasconi NL; Vanzetta F; Dander E; Sarasini A; Revello MG; Gerna G; Sallusto F; Lanzavecchia A
J Virol; 2010 Jan; 84(2):1005-13. PubMed ID: 19889756
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.
Lilleri D; Kabanova A; Lanzavecchia A; Gerna G
J Clin Immunol; 2012 Dec; 32(6):1324-31. PubMed ID: 22836657
[TBL] [Abstract][Full Text] [Related]
12. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
14. A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection.
Auerbach MR; Yan D; Vij R; Hongo JA; Nakamura G; Vernes JM; Meng YG; Lein S; Chan P; Ross J; Carano R; Deng R; Lewin-Koh N; Xu M; Feierbach B
PLoS Pathog; 2014 Apr; 10(4):e1004060. PubMed ID: 24722349
[TBL] [Abstract][Full Text] [Related]
15. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
Choi KY; McGregor A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ
PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505
[TBL] [Abstract][Full Text] [Related]
17. Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein.
Gardner TJ; Stein KR; Duty JA; Schwarz TM; Noriega VM; Kraus T; Moran TM; Tortorella D
Nat Commun; 2016 Dec; 7():13627. PubMed ID: 27966523
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
[TBL] [Abstract][Full Text] [Related]
19. Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells.
Qi Y; He L; Cui X; Hertel L; Freed DC; Fu TM; Kauvar LM; McVoy MA; Ruan Q
Virol J; 2020 Apr; 17(1):50. PubMed ID: 32268919
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.
Day LZ; Stegmann C; Schultz EP; Lanchy JM; Yu Q; Ryckman BJ
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
